how are compounding pharmacies still selling semaglutide Compounded Semaglutide: Safety & Regulation Guide The Risks of Compounded Semaglutide

The Medicines and Healthcare products Regulatory Agency (MHRA) approved tirzepatide following clinical trials demonstrating significant efficacy in HbA1c reduction and weight loss compared to placebo and some other diabetes treatments, including semaglutide 1 mg in the SURPASS-2 trial

Wegovy mimics the GLP-1 hormone thats released in the gastrointestinal tract when you eat, explains Jamie Alan, Ph.D., an associate professor of pharmacology and toxicology at Michigan State University

Join the Vitali Community and share your journey with us

Semaglutide is approved for the treatment of obesity in a subcutaneous formulation at a dose of 2.4 mg OW

If you are also considering tirzepatide, the same principles apply, and you can read about drinking on tirzepatide as well